Skip to content

Prospective study for the expression of KL-6 and CEA in pancreato-billiary cancer

Prospective study for the expression of KL-6 and CEA in pancreato-billiary cancer - Prospective study for the expression of KL-6 and CEA in pancreato-billiary cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000006725
Enrollment
120
Registered
2011-11-15
Start date
2011-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, Bile duct cancer

Interventions

None listed

Sponsors

Department of Gastroenterology, Tottori University School of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: pancreatic cancer, bile duct cancer, and suspected case of pancreatic cancer and bile duct cancer

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Sensitivity, Specificity, Accuracy

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026